Related Experiment Video
Updated: Oct 7, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Unravelling the pathophysiology of chronic kidney disease-associated pruritus
Severin Schricker1, Martin Kimmel2
1Department of General Internal Medicine and Nephrology, Robert-Bosch-Hospital, Stuttgart, Germany.
Abstract:
For decades, itch related to chronic kidney disease (CKDaP) has been a clinical problem, but the aetiology and pathophysiology of CKDaP are still not yet fully understood-currently the underlying pathophysiological mechanisms are thought to be multifactorial. As new therapeutic targets have recently been identified and clinical trials have shown promising results, our current understanding of the interrelationships has expanded significantly. Here we review the pathophysiology and recent findings on modulation and sensitization of itch contributing to the development of CKDaP, covering hypothesis regarding immune system dysfunction, metabolic changes, uremic toxin deposition, peripheral neuropathy and imbalances in the endogenous opioid system.
Insights
Chronic kidney disease (CKD) related pruritus (CKDaP) is a complex condition. Recent research has expanded our understanding of its multifactorial causes, including immune, metabolic, and neurologic factors.
Area of Science:
- Nephrology
- Dermatology
- Neuroscience
Background:
- Chronic kidney disease-associated pruritus (CKDaP) remains a significant clinical challenge.
- The exact causes and mechanisms of CKDaP are not fully understood.
- Current understanding suggests multifactorial origins for CKDaP.
Purpose of the Study:
- To review the pathophysiology of CKDaP.
- To discuss recent findings on itch modulation and sensitization in CKDaP.
- To cover emerging hypotheses on the contributing factors to CKDaP.
Main Methods:
- Literature review of existing research on CKDaP.
- Analysis of recent clinical trial data.
- Synthesis of current hypotheses regarding CKDaP.
Main Results:
- CKDaP is understood to involve complex interactions.
- Recent findings highlight the roles of immune dysfunction, metabolic changes, and uremic toxins.
- Peripheral neuropathy and opioid system imbalances are also implicated.
Conclusions:
- The pathophysiology of CKDaP is multifactorial, involving immune, metabolic, neural, and systemic factors.
- New therapeutic targets are emerging based on a deeper understanding of these mechanisms.
- Further research is needed to fully elucidate and treat CKDaP.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease IV: Nursing Management
Nephrons
Chronic Kidney Disease III: Interprofessional Care